ArticleJournal of cancer research and clinical oncology2016

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO).

C Kahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.